Vaccine dispute: Pfizer demands billions from Poland
The American pharmaceutical company Pfizer has taken legal action to recover 5.6 billion zlotys from Poland. The case concerns a failure to fulfill a contract for the supply of COVID-19 vaccines, which was concluded during the pandemic. The Polish government refused to accept and pay for subsequent batches of the preparations, which led to a long-standing legal dispute.
According to information reported by the media, Pfizer has won the legal dispute regarding payment for the ordered doses. Currently, the American giant is looking for ways to enforce the awarded amount. This situation puts the Polish authorities in a difficult budgetary position, as the need to pay such a large sum of money is a significant burden on public finances.
Experts point out that the consequences of this verdict could affect various sectors of the economy. There are concerns that the company's attempts to recover the debt could also affect other areas, including Polish aviation, although the details regarding the method of debt enforcement remain the subject of analysis by lawyers.
At this moment, the Polish government has not issued an official statement regarding the method of repaying the liability. The situation remains fluid, and market observers are following the next steps taken by both parties to the dispute. This case is currently one of the most important economic topics in the country.